protalix press release:Protalix BioTherapeutics to Announce Second Quarter ...
Protalix BioTherapeutics to Announce Second Quarter ...
5天前—CARMIEL,Israel,Aug.7,2024/PRNewswire/--ProtalixBioTherapeutics,Inc....Managementwillhostaconferencecallwithinvestorstodiscuss ...。其他文章還包含有:「PressReleases」、「ProtalixBioTherapeuticsReportsFirstQuarter2024...」、「ProtalixBioTherapeuticstoAnnounceFirstQuarter2024...」、「ProtalixBioTherapeuticsReportsFiscalYear2023Financial...」、「ProtalixBioTherapeutics」、「LatestPressRelea...
查看更多 離開網站Press Releases
https://ir.protalix.com
Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024 · Protalix BioTherapeutics to Host In-Person Investor ...
Protalix BioTherapeutics Reports First Quarter 2024 ...
https://www.prnewswire.com
Protalix's second product, Elfabrio®, was approved by both the FDA and the European Medicines Agency in May 2023. Protalix has partnered with ...
Protalix BioTherapeutics to Announce First Quarter 2024 ...
https://protalixbiotherapeutic
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024 ; Date: Friday, May 10, 2024 ; Time: 8:30 a.m. Eastern ...
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial ...
https://protalixbiotherapeutic
2023 was a significant year for Protalix , as we received regulatory approvals of Elfabrio for the treatment of adult patients with Fabry disease and advanced ...
Protalix BioTherapeutics
http://ir.protalix.com
August 7, 2024. Protalix BioTherapeutics to Announce Second Quarter 2024 Financial and Business Results on August 14, 2024 · June 13, 2024. Protalix ...
Latest Press Releases
https://www.nasdaq.com
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout.
Protalix BioTherapeutics
https://sg.finance.yahoo.com
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023 ... Protalix BioTherapeutics, Inc. (NYSE American:PLX), ...
Protalix BioTherapeutics
https://sg.finance.yahoo.com
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 ... Protalix BioTherapeutics, Inc. (NYSE American:PLX), a ...